• pufbx
• Mutual Fund
• Sector Equity
• Financial Services

PGIM Jennison Financial Services Fund- Class B

Expenses: 2.31% (Better than 0% of similar funds)

This is a bad choice for a Financial Services Sector Equity fund. See why »

• ryvnx
• Mutual Fund
• Alternative
• Inverse

Rydex Inverse NASDAQ-100® 2x Strategy Fund Class H

Expenses: 1.88% (Better than 0% of similar funds)

This is a bad choice for a Inverse Alternative fund. See why »

• sdmgx
• Mutual Fund
• International Stocks
• Emerging Markets

Sit Developing Markets Growth Fund

Expenses: 1.40% (Better than 0% of similar funds)

This is a bad choice for a Emerging Markets International Stocks fund. See why »

• slgyx
• Mutual Fund
• US Stocks
• Large Growth

Saratoga Large Capitalization Growth Portfolio Fund Class A

Expenses: 1.46% (Better than 0% of similar funds)

This is a bad choice for a Large Growth US Stocks fund. See why »

• spdcx
• Mutual Fund
• Allocation
• All-In-One

DWS Multi-Asset Conservative Allocation Fund - Class C

Expenses: 1.41% (Better than 0% of similar funds)

This is a bad choice for a All-In-One Allocation fund. See why »

• rgscx
• Mutual Fund
• Allocation
• Total World

AllianzGI Global Small-Cap Fund Class C

Expenses: 2.37% (Better than 0% of similar funds)

This is a bad choice for a Total World Allocation fund. See why »

• rmicx
• Mutual Fund
• Allocation
• All-In-One

RiverFront Asset Allocation Moderate Class C

Expenses: 1.25% (Better than 0% of similar funds)

This is a bad choice for a All-In-One Allocation fund. See why »

• rsgfx
• Mutual Fund
• US Stocks
• Mid-Cap Growth

Victory RS Select Growth Fund Class C

Expenses: 2.18% (Better than 0% of similar funds)

This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »

• ryahx
• Mutual Fund
• Alternative
• Leveraged Equities

Rydex Mid-Cap 1.5x Strategy Fund Class A

Expenses: 1.75% (Better than 0% of similar funds)

This is a bad choice for a Leveraged Equities Alternative fund. See why »

• rybox
• Mutual Fund
• Sector Equity
• Healthcare

Rydex Biotechnology Fund Class A

Expenses: 1.71% (Better than 0% of similar funds)

This is a bad choice for a Healthcare Sector Equity fund. See why »